Latest Research on Endomyocardial Fibrosis: Dec 2020

Posted on December 14, 2020December 26, 2020Categories CardiologyTags   Leave a comment on Latest Research on Endomyocardial Fibrosis: Dec 2020

Endomyocardial Fibrosis: Still a Mystery after 60 Years The pathologist Jack N. P. Davies identified endomyocardial fibrosis in Uganda in 1947. Since that time, reports of this restrictive cardiomyopathy have come from other parts of tropical Africa, South Asia, and South America. In Kampala, the disease accounts for 20% of heart disease patients referred for echocardiography. We conducted a systematic review of research on the epidemiology and etiology of endomyocardial fibrosis. We relied primarily on articles in the MEDLINE database … Continue reading “Latest Research on Endomyocardial Fibrosis: Dec 2020”

Latest Research on Blood Pressure: Jan – 2020

Posted on January 22, 2020Categories CardiologyTags ,   Leave a comment on Latest Research on Blood Pressure: Jan – 2020

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy This report updates the 1990 “National High vital sign Education Program working party Report on High vital sign in Pregnancy” and focuses on classification, pathophysiologic features, and management of the hypertensive disorders of pregnancy. Through a mixture of evidence-based medicine and consensus this report updates contemporary approaches to hypertension control during pregnancy by expanding on recommendations made in “The Sixth Report of the … Continue reading “Latest Research on Blood Pressure: Jan – 2020”

Latest News on Ischemic Stroke Research: Jan – 2020

Posted on January 9, 2020Categories CardiologyTags ,   Leave a comment on Latest News on Ischemic Stroke Research: Jan – 2020

Tissue Plasminogen Activator for Acute Ischemic Stroke BACKGROUND: therapy for acute ischaemic stroke has been approached cautiously because there have been high rates of intracerebral hemorrhage in early clinical trials. We performed a randomized, double-blind trial of intravenous recombinant tissue urokinase (t-PA) for ischaemic stroke after recent pilot studies suggested that t-PA was beneficial when treatment was begun within three hours of the onset of stroke. METHODS: The trial had two parts. Part 1 (in which 291 patients were enrolled) … Continue reading “Latest News on Ischemic Stroke Research: Jan – 2020”